VivoSeq
Other

Infection

4

Pipeline Programs↗

39

Active Trials↗

21

Companies Involved↗

Infection is an early-stage landscape with 4 programs across 21 companies. The most active players are Elion Therapeutics, Inc., LucasBio, AbbVie.

Intelligence

Pipeline Metrics

Competitive Density

48/100

Pipeline Velocity

42/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

E

Elion Therapeutics, Inc.

2 programs

Phase 2L

LucasBio

1 program

PreclinicalAbbVie logo

AbbVie

1 program

PreclinicalRoche logo

Roche

0 programs

PreclinicalM

Medicines Development for Global Health

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

161

clinical trials

Completed84 · 52%
Unknown status23 · 14%
Recruiting22 · 14%
Terminated10 · 6%
Active, not recruiting9 · 6%
Not yet recruiting8 · 5%
Other5 · 3%

Clinical Trials

Trial Activity

161 trials

Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
Recruiting·—·Phase 1·NCT06827470·60 enrolled
Study With Phage for CF Subjects With Pseudomonas Lung Infection
Recruiting·BBiomX, Inc.·Phase 2·NCT06998043·63 enrolled
Vaccine- and Infection-derived Correlates of Protection for Cholera.
Recruiting·MMassachusetts General Hospital·N/A·NCT06455852·1,221 enrolled
Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection
Recruiting·CCHU de Reims·N/A·NCT05888987·46 enrolled
European Trial Into Mpox Infection
Recruiting·—·Phase 4·NCT06156566·150 enrolled
Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults
Recruiting·GGeorge Washington University·Phase 1·NCT05706116·18 enrolled
Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.
Recruiting·—·N/A·NCT04160455·180 enrolled
ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
Recruiting·SShoklo Malaria Research Unit·Phase 4·NCT05788094·606 enrolled
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Recruiting·UUniversity of Oxford·Phase 1·NCT05959616·70 enrolled
Analysis of Clinical Outcomes and Host Immune Response to Vascular Graft and Endograft Infections
Recruiting·AAarhus University Hospital·N/A·NCT07696884·300 enrolled
A Phase 2, Multicenter, Randomized, Double-blind Study of Safety and Efficacy of EL219 (Turletricin) Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy of Invasive Mould Infections (TREAT-1)
Recruiting·EElion Therapeutics, Inc.·Phase 2·NCT07215273·60 enrolled
Cryptococcosis in Previously Healthy Adults
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT00001352·800 enrolled
Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP)
Recruiting·National Institute of Neurological Disorders and Stroke (NINDS)·N/A·NCT00001778·750 enrolled
A Prospective Clinical Study to Evaluate the Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.
Recruiting·LLucasBio·Preclinical·NCT07685457·6 enrolled
Impact of Molecular Microbiology Integrated With Clinical Data on Antimicrobial Therapy Optimization: An Open-Label Cluster-Randomized Crossover Trial
Recruiting·—·Preclinical·NCT07684300·250 enrolled
Page 1 of 11

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)